Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | BMY | GSK | ||
| Company | Vertex Pharmaceutic | Bristol-Myers Squibb | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 537.47 | 66.80 | 51.40 | ||
| High | 553.69 | 68.64 | 52.95 | ||
| Low | 532.55 | 66.61 | 51.35 | ||
| Last | 552.06 | 67.61 | 52.88 | ||
| Change | +23.87 | +1.56 | +1.73 | ||
| Percent Change | +4.52% | +2.36% | +3.38% | ||
| Volume | 1,437,700 | 13,889,200 | 3,902,400 | ||
| 20-Day Average Volume | 1,365,645 | 12,539,995 | 4,144,975 | ||
| Previous | 528.19 | 66.05 | 51.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 498.68 | 64.29 | 51.60 | ||
| 20-Day Raw Stochastic | 98.16% | 87.42% | 58.05% | ||
| 20-Day Relative Strength | 68.22 | 66.01 | 54.48 | ||
| Weighted Alpha | +44.44 | +45.28 | +24.50 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 56% Buy | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.01% since 08/12/26 | +6.14% since 08/12/26 | +5.13% since 08/12/26 | ||
| Low | 502.29 on 08/14/26 | 63.35 on 08/14/26 | 48.86 on 08/14/26 | ||
| High | 553.69 on 08/19/26 | 68.64 on 08/19/26 | 52.94 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +13.67% since 07/17/26 | +11.31% since 07/17/26 | +2.16% since 07/17/26 | ||
| Low | 465.00 on 07/23/26 | 59.80 on 07/21/26 | 48.86 on 08/14/26 | ||
| High | 553.69 on 08/19/26 | 68.64 on 08/19/26 | 55.78 on 07/28/26 | ||
| 3-Month | |||||
| %Chg | +27.11% since 05/19/26 | +15.95% since 05/19/26 | +3.58% since 05/19/26 | ||
| Low | 420.01 on 06/03/26 | 53.44 on 06/18/26 | 48.57 on 06/02/26 | ||
| High | 553.69 on 08/19/26 | 68.64 on 08/19/26 | 55.78 on 07/28/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 02/19/26 | +12.12% since 02/19/26 | -13.10% since 02/19/26 | ||
| Low | 412.27 on 05/05/26 | 53.44 on 06/18/26 | 48.57 on 06/02/26 | ||
| High | 553.69 on 08/19/26 | 68.64 on 08/19/26 | 60.05 on 02/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 134,057,264 | 134,921,328 | 103,461,008 | ||
| Shares Outstanding, K | 253,805 | 2,042,715 | 2,022,698 | ||
| Annual Sales, $M | 12,001,300,000 | 48,194,000,000 | 43,077,970,000 | ||
| Annual Net Income, $M | 3,953,200,000 | 7,054,000,000 | 7,537,690,000 | ||
| Last Qtr Sales, $M | 3,333,900,000 | 12,973,000,000 | 11,285,720,000 | ||
| Last Qtr Income, $M | 1,099,800,000 | 3,317,000,000 | 583,810,000 | ||
| 60-Month Beta | 0.30 | 0.22 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.73 on 08/03/26 | 2.04 on 07/30/26 | 1.36 on 07/28/26 | ||
| Latest Earnings Date | 11/02/26 | 10/29/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | 0.630 on 07/02/26 | 0.444 on 08/14/26 | ||
| Next Ex-Dividend Date | N/A | 07/02/26 | 08/14/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 30.29 | 9.93 | 10.56 | ||